Sign Up to like & get
recommendations!
1
Published in 2022 at "Molecular cancer therapeutics"
DOI: 10.1158/1535-7163.mct-22-0527
Abstract: Prostate Cancer (PCa) is a global health concern that has a low survival rate in its advanced stages. Even though second-generation androgen receptor (AR)-axis inhibitors serve as the mainstay treatment options, utmost of the metastatic…
read more here.
Keywords:
prostate cancer;
therapy;
developments ets;
emerging developments ... See more keywords